Intranasal Vaccine Booster Sarbecoviruses: NUS-Monash Study | AcademicJobs
NUS Medicine and Monash researchers develop Clec9A-OMNI intranasal booster, offering durable cross-clade immunity against sarbecoviruses superior to mRNA shots. Explore implications for higher ed research.
pandemic-preparednesssingapore-higher-educationresearch-publication-news

